These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33921148)

  • 1. An aMMP-8 Point-of-Care and Questionnaire Based Real-Time Diagnostic Toolkit for Medical Practitioners.
    Räisänen IT; Lähteenmäki H; Gupta S; Grigoriadis A; Sahni V; Suojanen J; Seppänen H; Tervahartiala T; Sakellari D; Sorsa T
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33921148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis.
    Lähteenmäki H; Tervahartiala T; Räisänen IT; Pärnänen P; Mauramo M; Gupta S; Sampson V; Rathnayake N; Heikkinen AM; Alassiri S; Gieselmann DR; Frankenberger R; Sorsa T
    Clin Exp Dent Res; 2022 Apr; 8(2):485-496. PubMed ID: 35118828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active MMP-8 (aMMP-8) as a Grading and Staging Biomarker in the Periodontitis Classification.
    Sorsa T; Alassiri S; Grigoriadis A; Räisänen IT; Pärnänen P; Nwhator SO; Gieselmann DR; Sakellari D
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31979091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active Matrix Metalloproteinase-8 Point-of-Care (PoC)/Chairside Mouthrinse Test vs. Bleeding on Probing in Diagnosing Subclinical Periodontitis in Adolescents.
    Räisänen IT; Sorsa T; van der Schoor GJ; Tervahartiala T; van der Schoor P; Gieselmann DR; Heikkinen AM
    Diagnostics (Basel); 2019 Mar; 9(1):. PubMed ID: 30909530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.
    Sorsa T; Nwhator SO; Sakellari D; Grigoriadis A; Umeizudike KA; Brandt E; Keskin M; Tervahartiala T; Pärnänen P; Gupta S; Mohindra R; Bostanci N; Buduneli N; Räisänen IT
    Front Oral Health; 2022; 3():897115. PubMed ID: 35757444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
    Räisänen IT; Aji NRAS; Sakellari D; Grigoriadis A; Rantala I; Pätilä T; Heikkilä P; Gupta S; Sorsa T
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.
    Gupta S; Mohindra R; Singla M; Khera S; Kumar A; Rathnayake N; Sorsa T; Pfützner A; Räisänen IT; Soni RK; Kanta P; Jain A; Gauba K; Goyal K; Singh MP; Ghosh A; Kajal K; Mahajan V; Suri V; Bhalla A
    Clin Exp Dent Res; 2022 Aug; 8(4):988-1001. PubMed ID: 35818743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediabetes/Diabetes Can Be Screened at the Dental Office by a Low-Cost and Fast Chair-Side/Point-of-Care aMMP-8 Immunotest.
    Grigoriadis A; Sorsa T; Räisänen I; Pärnänen P; Tervahartiala T; Sakellari D
    Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31627410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of active matrix metalloproteinase-8 (aMMP-8) chair-side test as a diagnostic biomarker in the staging of periodontal diseases.
    Öztürk VÖ; Emingil G; Umeizudike K; Tervahartiala T; Gieselmann DR; Maier K; Köse T; Sorsa T; Alassiri S
    Arch Oral Biol; 2021 Apr; 124():104955. PubMed ID: 33556789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral active matrix metalloproteinase-8 immunotest may be less accurate in haemato-oncologic patients.
    Mauramo M; Uutela P; Sorsa T; Tervahartiala T; Bornstein MM; Waltimo T
    Oral Dis; 2024 Mar; 30(2):624-630. PubMed ID: 35925017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparative Analysis of Treatment-Related Changes in the Diagnostic Biomarker Active Metalloproteinase-8 Levels in Patients with Periodontitis.
    Keskin M; Rintamarttunen J; Gülçiçek E; Räisänen IT; Gupta S; Tervahartiala T; Pätilä T; Sorsa T
    Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting.
    Lähteenmäki H; Umeizudike KA; Heikkinen AM; Räisänen IT; Rathnayake N; Johannsen G; Tervahartiala T; Nwhator SO; Sorsa T
    Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32764436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of chairside salivary aMMP-8 findings with periodontal risk assessment parameters in patients receiving supportive periodontal therapy.
    Schmalz G; Kummer MK; Kottmann T; Rinke S; Haak R; Krause F; Schmidt J; Ziebolz D
    J Periodontal Implant Sci; 2018 Aug; 48(4):251-260. PubMed ID: 30202608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
    Sorsa T; Sahni V; Buduneli N; Gupta S; Räisänen IT; Golub LM; Lee HM; Pätilä T; Bostanci N; Meurman J; Pärnänen P; Nwhator SO; Singla M; Gauba K
    Expert Rev Proteomics; 2021 Aug; 18(8):707-717. PubMed ID: 34468272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Oral Rinse Active Matrix Metalloproteinase-8 Point-of-Care Immunotest May Be Less Accurate in Patients with Crohn's Disease.
    Rautava J; Gürsoy UK; Kullström A; Könönen E; Sorsa T; Tervahartiala T; Gürsoy M
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32143418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediabetes/diabetes screening strategy at the periodontal clinic.
    Grigoriadis A; Räisänen IT; Pärnänen P; Tervahartiala T; Sorsa T; Sakellari D
    Clin Exp Dent Res; 2021 Feb; 7(1):85-92. PubMed ID: 33300692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of active matrix metalloproteinase-8 point-of-care test for the discrimination of periodontal health status: Comparison of saliva and oral rinse samples.
    Deng K; Wei S; Xu M; Shi J; Lai H; Tonetti MS
    J Periodontal Res; 2022 Aug; 57(4):768-779. PubMed ID: 35575900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of a point-of-care aMMP-8 test in the discrimination of periodontal health and disease.
    Deng K; Pelekos G; Jin L; Tonetti MS
    J Clin Periodontol; 2021 Aug; 48(8):1051-1065. PubMed ID: 33998040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot Study on Oral Health Status as Assessed by an Active Matrix Metalloproteinase-8 Chairside Mouthrinse Test in Adolescents.
    Heikkinen AM; Nwhator SO; Rathnayake N; Mäntylä P; Vatanen P; Sorsa T
    J Periodontol; 2016 Jan; 87(1):36-40. PubMed ID: 26430926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic ability of salivary matrix metalloproteinase-9 lateral flow test point-of-care test for periodontitis.
    Kim HD; Lee CS; Cho HJ; Jeon S; Choi YN; Kim S; Kim D; Jin Lee H; Vu H; Jeong HJ; Kim B
    J Clin Periodontol; 2020 Nov; 47(11):1354-1361. PubMed ID: 32841379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.